GlassScriptPhysician profile
Paul D Haas
NPI 1124249560
$136,214.92
in general payments reported to CMS, 2019-2025
27 companies · $38K in 2025
The $38K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $9,011 · 2021: $3,756 · 2022: $11K · 2023: $14K · 2024: $10K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $7,357 · Travel and Lodging: $6,071 · Education: $12.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,909.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,625.00 |
| Food and Beverage | $7,356.67 |
| Travel and Lodging | $6,070.68 |
| Education | $12.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $63,656.98 | 2019-2025 | Advisor, Aveir, Ensite |
| Biosense Webster, INC. | $38,411.36 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $27,235.16 | 2019-2025 | Watchman Access System, Watchman Flx, Rhythmia Mapping System |
| Medtronic, INC. | $3,302.91 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Linq II |
| Philips North America LLC | $872.66 | 2019-2024 | (Am5) Lead Management |
| Medtronic Vascular, INC. | $728.18 | 2019-2020 | |
| Cardiva Medical, INC. | $562.75 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Optowire |
| Impulse Dynamics (USA) INC. | $338.08 | 2021-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $174.33 | 2019-2022 | |
| Amgen INC. | $123.37 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $116.50 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $110.66 | 2020-2023 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.82 | 2019-2025 | Lifevest |
| Stryker Corporation | $72.98 | 2019 | |
| Kestra Medical Technology Services, INC. | $67.65 | 2025 | Assure Wcd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.96 | 2019-2023 | Jardiance |
| Cleerly, INC. | $51.71 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Bardy Diagnostics, INC. | $50.00 | 2022 | |
| Abiomed | $37.63 | 2021-2023 | Impella |
| Inspire Medical Systems, INC. | $30.68 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $28.21 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $23.02 | 2022 | |
| Pfizer INC. | $18.08 | 2025 | |
| Cvrx, INC. | $15.97 | 2023 | Barostim Neo System |
| Biotronik INC. | $14.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.55 | 2020 | |
| Atricure, INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.